EarningsQ4 2020 Earnings Report

Diaceutics (7DC) Q4 2020 Earnings Report

0 Followers

DE:7DC Q4 2020 EPS Results

Actual EPS-€0.01

Consensus EPS―

Beat/Miss―

One Year Ago EPS€0.04

Actual Revenue€8.60M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-18.48%

QuarterQ4 2020

Date03/15/2021

TimeBefore Open

Conference CallMonday, March 15, 2021

DE:7DC Upcoming Earnings

Diaceutics's next earnings date is estimated for March 15, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 15, 2027	2026 (Q4)	0.04 / -	0.035	―
Sep 22, 2026	2026 (Q2)	-0.03 / -0.04	-0.033	-17.86% (>-0.01)
May 26, 2026	2025 (Q4)	0.03 / 0.03	0.012	200.00% (+0.02)
Sep 23, 2025	2025 (Q2)	-0.03 / -0.03	-0.036	9.68% (<+0.01)
May 13, 2025	2024 (Q4)	0.02 / 0.01	-0.003	433.33% (+0.02)
Sep 17, 2024	2024 (Q2)	-0.04 / -0.04	-0.021	-72.22% (-0.02)
May 21, 2024	2023 (Q4)	<0.01 / >-0.01	0.021	-116.67% (-0.02)
Sep 26, 2023	2023 (Q2)	- / -0.02	-0.01	-100.00% (-0.01)
Apr 17, 2023	2022 (Q4)	0.02 / 0.02	0.013	63.64% (<+0.01)
Sep 27, 2022	2022 (Q2)	- / -0.01	-0.005	-125.00% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed